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Benign peripheral nerve sheath tumor of the perianal region in a young pony
Ben P. R. Sturgeon, Elspeth M. Milne,1 Kenneth C. Smith
Abstract. A 20 3 10 cm, lobulated mass was present in the perianal region of a 4-year-old Dales pony.
Histopathology revealed an unencapsulated, loose arrangement of sheets and whorls of narrow mesenchymal
cells, situated in the deep dermis. Intervening areas had a myxomatous appearance. The whorls were often
arranged around a central structure resembling an axon or a vascular structure. Immunohistochemistry
revealed that the elongated mesenchymal cells and central axon-like structures expressed vimentin, S-100, and
neuron-specific enolase, but not pancytokeratin, glial fibrillary acid protein, and the neurofilament markers,
NR4 and 2F11. On the basis of the histopathology and immunohistochemistry, a diagnosis of benign
peripheral nerve sheath tumor (schwannoma type) was made. This case was unusual in that the concentric
laminations of Schwann cells were very loosely arranged, with an intervening myxomatous stroma (Antoni
type B appearance) and despite its benign histological appearance, the mass extended deeply to the proximal
sacral vertebrae. Its exact origin was unclear; it may have arisen from cutaneous nerves with deep extension or
from neural structures in the sacral region. Due to the incomplete surgical removal, regrowth of the mass
occurred.
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Peripheral nerve sheath tumors (PNSTs) are derived
from Schwann cells, axons, and perineural connective tissue
elements and can be benign or malignant. In humans,
PNSTs are subclassified as benign (BPNSTs) or malignant
(MPNSTs). Neoplasms subclassified as BPNSTs include
schwannomas and neurofibromas.15 In veterinary litera-
ture, these subclassifications are less well recognized, and
mesenchymal tumors of the skin and soft tissues in
domestic animals often combine malignant and benign
forms of neurofibroma and schwannoma under the title of
peripheral nerve sheath tumor,10 although more recently,
clearer distinctions have been proposed.3
Benign peripheral nerve sheath tumors are relatively
common in humans but occur infrequently in domestic
animals, with most frequent reports in cattle and
dogs.3,5,8,16 In humans, the schwannoma type of BPNST
account for an estimated 8% of intracranial2 and 29% of
primary spinal tumors.5,18 Benign peripheral nerve sheath
tumors generally present as slow growing tumors that can
be located anywhere in the peripheral nervous system
(PNS) but are most frequent at the intracranial segment of
the eighth cranial nerve.15 They occur very rarely in horses
but have been described in the periorbital region,12
extradurally in the cranium,17 in the small intestine,9 in
the skin, and in the spinal cord.15 This paper describes the
histopathological and immunohistological features of an
unusual BPNST affecting the perianal and sacral region of
a young pony.
A 4-year-old crossbred Dales pony gelding weighing
approximately 450 kg was presented with a mass located at
the junction between the left lateral aspect of the tail head
and the perianal region (Fig. 1). The mass had been present
for approximately 3 months and had slowly increased
in size during this period, without any other clinical signs.
The mass was approximately 20 3 10 cm, smooth, partially
alopecic, nonulcerated, firm on palpation, movable locally,
and appeared to be dermal to subcutaneous. No lymph-
adenopathy was identified on external and internal (rectal)
lymph node palpation, and no further significant clinical
abnormalities were evident. Ultrasonographic examination
identified a multilobulated, homogeneous structure
present within the deep dermis and extending deep into
the gluteal musculature. The deepest margins of the mass
could not be visualized adequately on ultrasonographic
evaluation.
After discussion with the owner, surgical resection was
carried out under general anesthesia with the horse in
dorsal recumbency, by blunt dissection of the mass from
the surrounding tissues. Despite removal of the more
superficial margins of the mass, further dissection revealed
that the mass involved the proximal sacral vertebrae and
complete excision was not possible. The wound was
allowed to heal by secondary intention. Over the following
3 years, the mass has slowly regrown.
The resected tissue was fixed in 10% phosphate-buffered
formalin (pH 7.4). Tissues were embedded in paraffin wax
and sections (4 mm) were cut, processed by routine
methods, and stained with hematoxylin and eosin and
Masson’s trichrome. Consecutive sections to those used for
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the histopathological examination were immunolabeled for
vimentin,a pancytokeratin (CK),b S-100,c glial fibrillary acid
protein (GFAP),d neuron-specific enolase (NSE),e and the
neurofilament markers NR4f and 2F11.g
Immunolabeling was carried out on fixed paraffin wax-
embedded sections (4 mm). For vimentin, CK, S-100,
GFAP, and NSE, sections were cut onto coated slides.h
The sections were dewaxed, hydrated, and pretreated in
citrate buffer for 4 minutes in a plastic pressure cookeri
followed by quenching in H2O2 1.0% in methanol for
20 minutes. To prevent nonspecific binding, sections were
treated with 2.5% normal horse serum for 20 minutes. They
were then incubated for 1 hour with the appropriate
primary antibody diluted 1/50 (vimentin), 1/100 (CK),
1/1000 (S-100), 1/50 (GFAP), or 1/6 (NSE). The secondary
antibody (biotinylated horse antimouse IgG) j was then
applied for 30 minutes, followed by the avidin-biotin
complexj for 30 minutes. Immunoreactivity was then
visualized with horseradish peroxidase using diaminoben-
zidine (DAB) as the substrate.k
For NR4 and 2F11 immunohistochemistry, sections were
cut onto capillary gap slides, incubated overnight, dewaxed,
and hydrated. Those for NR4 were pretreated by placing
the slides in distilled water and gently heating in running
tap water. The slides were then transferred to preheated
citrate target retrieval solution,l microwaved on medium-
high for 10 minutes, and then incubated at room temper-
ature for 20 minutes. The slides were then cooled in
running tap water and washed in Tris buffered saline
Tween-20 (TBST). The anti-NR4 antibody was optimized
at 1:50. For 2F11, no antigen retrieval was required, and
the anti-2F11 antibody was optimized at 1:200. For NR4
and 2F11, peroxidase blockingm was used to prevent
nonspecific staining due to endogenous peroxidase. This
was followed by detection using DAB.n All immunohisto-
chemical sections were counterstained with hematoxylin.
Negative controls were prepared by replacing the primary
antisera (vimentin, CK, S-100, GFAP, NSE, NF4, or 2F11)
with normal rabbit or mouse serum, as appropriate. This
resulted in complete absence of immunolabeling. Positive
Figure 1. Mass located at the junction between the left
lateral aspect of the tail head and the perianal region of a 4-year-
old Dales pony.
Figure 2. Benign peripheral nerve sheath tumor showing
loose whorls of mesenchymal cells with small, elongated hyper-
chromatic nuclei (Antoni type B appearance) arranged around
a central structure resembling a focus of epithelioid tumor cells.
Hematoxylin and eosin, 203.
Figure 3. Benign peripheral nerve sheath tumor showing
loose whorl of mesenchymal cells with small, elongated hyper-
chromatic nuclei (Antoni type B appearance) arranged around
a central structure resembling a focus of epithelioid tumor cells. S-
100, 403.
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controls were based on the use of tissue from normal control
animals in which abundant immunoreactivity for these
antigens had previously been demonstrated.
Histopathology revealed a neoplastic mass extending
from the deep dermis into the subcutaneous tissues.
Overlying hair follicles and adnexal glands were normal,
and the epidermis was intact. The mass was unencapsulated
and consisted of multiple lobules with an intervening
collagenous stroma (Fig. 2). Within the lobules was a loose
arrangement of sheets and whorls of mesenchymal cells
with a palely eosinophilic, extended, poorly defined
cytoplasm and small, elongated hyperchromatic nuclei
(Antoni type B appearance). Short linear arrangements of
more plump mesenchymal cells were also present. In some
areas, a palely eosinophilic, finely granular material was
present within the spaces formed by the loose stroma,
giving a myxomatous appearance. The whorls were often
arranged around a central structure resembling an axon
(Fig. 2) or, in some areas, a vascular structure. No mitoses
were seen. Staining with Masson’s trichrome showed
moderate amounts of collagen forming an irregular, loose
stroma with occasional denser collagen bundles within the
lobules and surrounding the nuclei of the central axon-like
structures. Dense collagen was present in the interlobular
connective tissue.
Immunohistochemistry showed that the elongated mes-
enchymal cells and the central axon-like structures ex-
pressed vimentin, S-100 (Fig. 3), and NSE, but not CK,
GFAP, NR4, and 2F11. Vimentin expression was also
present in the connective tissue between the lobules. On the
basis of the histopathology and immunohistochemistry,
a diagnosis of BPNST (schwannoma type) was made.
PNSTs are recorded in horses worldwide although their
prevalence appears very low, with a wide age range of cases
ranging from 1 month to 24 years old.15 The distribution of
lesions is equally variable with extradural, cervical spinal
cord, mediastinal, gastrointestinal, cutaneous, cardiac, and
periocular sites recorded.1,9,14,15,17
In humans, clinical signs associated with PNSTs are
variable and relate both to space-occupying or conductive
effects. The latter is influenced by whether their origin is
proximal or distal to the affected ganglion.19 In horses, the
clinical manifestations reflect this with records of colic,9
central nervous signs,15,17 or space-occupying effects.15 The
clinical progression of this case was insidious due to its
ability to expand without major alteration in function of
surrounding structures and without causing obvious pain.
The differential diagnosis on presentation included sarcoid,
fibroma, fibrosarcoma, leiomyoma, leiomyosarcoma, mel-
anoma, and lymphoma in addition to BPNSTs and
MPNSTs.3,4,11,12,16
Macroscopically, benign schwannomas of domesticated
animals are usually encapsulated, globoid, lobulated
masses of variable size and shape, depending on location
of the neoplasm and animal species affected.1,13,16 Malig-
nant schwannomas are usually nonencapsulated and in-
filtrative. Microscopically, the classical description of
schwannomas is characterized by Antoni type A and B
patterns and Verocay body formation.4 Antoni type A
pattern is characterized by a parallel arrangement of
Schwann cell fusiform nuclei, giving a palisaded pattern.
Antoni type B areas are more loosely arranged with fewer
cells, smaller, round dark nuclei, separated by dense,
closely aligned, eosinophilic cell processes1; this pattern
predominated in the current case. Peripheral nerve sheath
tumors lacking these classical morphologic patterns are
often difficult to differentiate from other spindle cell
tumors without recourse to immunohistochemistry. In
addition, BPNSTs and MPNSTs can be difficult to
differentiate, and in 1 study in dogs, mitotic index, growth
pattern, cellularity, cellular pleomorphism, and necrotic
foci were found to be useful criteria.3 In the present study,
the benign histological appearance of the lesion (low
mitotic index, lack of cellular pleomorphism or necrosis)
occurred in conjunction with deeply infiltrative growth and
recurrent behavior. This illustrates how histological assess-
ment of recurrent potential for this type of tumor requires
both assessment of the cellular characteristics and the
marginal behavior, which may necessitate collection of
several incisional biopsies (from the center and from the
edge of the lesion) or collection of an excisional biopsy.
The criteria used in this study for diagnosis of a BPNST
of the schwannoma subclassification were based on
a grossly encapsulated, globoid, and lobulated mass with
loosely arranged sheets and whorls of typical tumor cells
(Antoni type B). Additional immunohistochemistry re-
vealed that the tumor expressed vimentin, S-100, and NSE,
consistent with previous reports.3 Positive staining for
GFAP was not present in the whorls of neoplastic cells and
is known to be variable in PNSTs.3,15 However, the central
structures, which resembled axons on routine stains, were
negative for GFAP and neurofilament markers. Possible
explanations for this negative staining were that these
structures were not axons, were axons that were not
showing expected immunohistochemical characteristics, or
were foci of epithelioid tumor cells seen in some PNSTs.3
Concentric laminations of perineural cells around individ-
ual axons occurs in perineuromas, giving some histological
similarities to the present case, but perineuromas are
negative for S-1006 and that diagnosis was therefore
discounted.
This case was unusual in 2 respects: the concentric
laminations of Schwann cells were very loosely arranged,
with an intervening myxomatous stroma containing a mod-
erate amount of collagen and despite its benign histological
appearance, the mass extended deeply to the proximal
sacral vertebrae. Thus its exact origin was unclear; it may
have arisen from cutaneous nerves with deep extension or
from neural structures in the sacral region. Due to the
incomplete surgical removal, regrowth of the mass is
unsurprising.
Sources and manufacturers
a. Vimentin, mouse monoclonal antibody, NCL-L VIM-V9,
Novocastra, Newcastle, UK.
b. Pancytokeratin, mouse monoclonal antibody, MNF116,
M0821, Dako, Ely, UK.
c. S-100, rabbit polyclonal antibody, Z0311, Dako, Ely, UK.
d. GFAP, mouse monoclonal antibody, M07651, Dako, Ely, UK.
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e. NSE, mouse monoclonal antibody, AM055-5M, BioGenex,
San Ramon, CA.
f. Mouse antineurofilament protein NR4, M0726, Dako, Ely,
UK.
g. Mouse antineurofilament protein 2F11, M0762, Dako, Ely,
UK.
h. Thermo Electron, Runcorn, Cheshire, UK.
i. Menarini Diagnostics Ltd., Wokingham, Berks, UK.
j. RTU Vectastain Universal Elite ABC kit, PK7200, Vector
Laboratories, Burlingame, CA.
k. Peroxidase Substrate kit, SK4100, Vector Laboratories, Bur-
lingame, CA.
l. REAL Target Retrieval Solution Citrate pH 6 (310), S2369,
Dako, Ely, UK.
m. REAL Peroxidase Blocking Solution, S2023, Dako, Ely,
UK.
n. REAL Envision Detection Kit HRP Mouse/Rabbit, K5007,
Dako, Ely, UK.
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